CIK 0001770121
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Sana Biotechnology, Inc.
Sign in to watch- Ticker
- SANA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831381173
- Phone
- +1 206-701-7914
- Business address
- 188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA
- 4 Grant or award Director acquired 4,901 shares (grant or award)
- 4 Grant or award Director acquired 1,470 shares (grant or award)
- 4 Planned sale EVP, Chief Business Officer sold 75,000 shares at $4.00 ($300,098)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 2,077 shares (grant or award)
- 4 Grant or award Director acquired 6,925 shares (grant or award)
- 4 Other disposition 10% owner disposed of 11,781,275 shares (other)
- 4 Grant or award Director acquired 1,245 shares (grant or award)
- 4 Grant or award Director acquired 4,152 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 403,758 shares at an average $6.27 ($2,532,858)
Page 5 of 10 · 193 filings